IgE antibodies against Trypanosoma cruzi arginine kinase in patients with chronic Chagas disease

2021 ◽  
Vol 138 ◽  
pp. 68-75
Author(s):  
Edward Augusto Valera-Vera ◽  
Juan Luis Concepción ◽  
Ana Judith Cáceres ◽  
Gonzalo Raúl Acevedo ◽  
Marisa Fernández ◽  
...  
2017 ◽  
Vol 11 (7) ◽  
pp. e0005796 ◽  
Author(s):  
Ingebourg Georg ◽  
Alejandro Marcel Hasslocher-Moreno ◽  
Sergio Salles Xavier ◽  
Marcelo Teixeira de Holanda ◽  
Eric Henrique Roma ◽  
...  

2019 ◽  
Vol 13 (2) ◽  
pp. e0007168 ◽  
Author(s):  
María A. Natale ◽  
Gonzalo Cesar ◽  
Maria G. Alvarez ◽  
Melisa D. Castro Eiro ◽  
Bruno Lococo ◽  
...  

1998 ◽  
Vol 12 (14) ◽  
pp. 1551-1558 ◽  
Author(s):  
Masako Oya Masuda ◽  
Mariano Levin ◽  
Selma Farias De Oliveira ◽  
Patricia C. Dos Santos Costa ◽  
Pablo Lopez Bergami ◽  
...  

1982 ◽  
Vol 31 (3) ◽  
pp. 452-458 ◽  
Author(s):  
Renato d'A. Gusmāo ◽  
Joffre M. Rezende ◽  
Anis Rassi ◽  
Albert A. Gam ◽  
Franklin A. Neva

1989 ◽  
Vol 22 (3) ◽  
pp. 147-156 ◽  
Author(s):  
João Carlos Pinto Dias

Data on the epidemiology and the natural history of the indeterminate form of human chronic Chagas' disease (IFCCD) are discussed, revealing its great importance in endemic areas of Brazil. The work shows that IFCCD presents a gradual and very slow course, causing a benign picture in the studied patients. Evolution patterns, prognostic and anatomopathological features are also discussed. For practical purposes, the classical concept of IFCCD proved to be simple, operational and consistent, It is defined by the absence of symptoms and clinical findings in chronic infected patients with positive serology and/or parasitological examinations for Trypanosoma cruzi coupled with normal electrocardiographic and radiological exams (heart, oesophagus and colon X-Rays). If a patient is submitted to more rigorous and sophisticated tests, these can reveal some alterations, generally small ones and unable to interfere with the prognosis of the infection. It is suggested that research lines specially related to the evolution ary factors and immunological involvement during this phase be adopted.


2012 ◽  
Vol 61 (4) ◽  
pp. 735-737 ◽  
Author(s):  
Miguel H. Vicco ◽  
Iván Bontempi ◽  
Silvia Ortiz ◽  
Aldo Solari ◽  
Oscar A. Bottasso ◽  
...  

Cytokine ◽  
2012 ◽  
Vol 58 (2) ◽  
pp. 207-212 ◽  
Author(s):  
Adriene Siqueira de Melo ◽  
Virginia Maria Barros de Lorena ◽  
Suellen Carvalho de Moura Braz ◽  
Cássia Docena ◽  
Yara de Miranda Gomes

Sign in / Sign up

Export Citation Format

Share Document